LAKE FOREST, Ill., April 07, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to patients, announced that effective April 3, 2023, the Compensation Committee of the Company’s Board of Directors granted two newly-hired employees a total of 20,542 restricted stock units (“RSUs”) and 24,018 stock options (“options”).
Follow this link:
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Recommendation and review posted by Fredricko
